Evaluation and treatment of hypertension in active individuals

Medicine and Science in Sports and Exercise

Volumn 30, Issue 10 SUPPL., 1998, Pages

  Orbach, Pini ^b   Lowenthal, David T ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Athlete; Elderly; Exercise; Hypertension; Obesity; Postmenopausal women

Indexed keywords

DIET THERAPY; HEMODYNAMICS; HUMAN; HYPERTENSION; KINESIOTHERAPY; REVIEW; SPORTS MEDICINE; WEIGHT REDUCTION;

EID: 0031670489     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005768-199810001-00004     Document Type: Review

References (137)

1. AMERICAN COLLEGE OF SPORTS MEDICINE (ACSM). Guidelines for Exercise Testing and Prescription. Philadelphia: Lea and Febiger, 1991, pp. 55-60.
2. APPEL, L. J., T. J. MOORE, E. OBARZANEK, et al. A clinical trial of the effects of dietary patterns on BP. DASH Collaborative Research Group. N. Engl. J. Med. 336:117-1124, 1997.
3. AUSTRALIAN NATIONAL HEALTH AND RESEARCH COUNCIL DIETARY SALT STUDY MANAGEMENT COMMITTEE. Fall in BP with modest reduction in dietary salt intake in mild hypertension. Lancet 1:399-402, 1989.
4. BLACK, H. R. Metabolic considerations in the choice of therapy for the patient with hypertensive. Am. Heart J. 121:707-715, 1991.
5. BINDER, E. F., S. J. BIRGE, and W. M. KOHRT. Effects of endurance exercise and hormone replacement therapy on serum lipids in older women. J. Am. Geriatr. Soc. 44:231-326, 1996.
6. BLAIR, S. N., N. N. GOODYEAR, L. W. GIBBONS, and K. H. COOPER. Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA 252:487-490, 1984.
7. BONOW, R. O., M. B. LEON, D. R. ROSING, et al. Effects of verapamil and propranolol on left ventricular function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise. Circulation 65:1337-1350, 1982.
8. BRAITH, R. M., M. L. POLLOCK, D. T. LOWENTHAL, J. E. GRAVES, and M. C. LIMACHER. Moderate-and high intensity exercise lowers BP in normotensive subjects 60 to 79 years of age. Am. J. Cardiol. 73:1124-1128, 1994.
9. BRICKMAN, A. S., S. G. MASSRY, and J. W. COBURN. Changes in serum and urinary calcium during treatment with hydrochlorothiazide: studies on mechanisms. J. Clin. Invest. 51:945-954, 1972.
10. BUSH, T. L., and E. BARRETT-CONNOR. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol. Rev. 7:80-104, 1985.
11. CADE, R., D. MARS, H. WAGEMAKER, et al. Effect of aerobic exercise training on patients with systemic arterial hypertension. Am. J. Med. 77:785-790, 1984.
12. CASTELLI, W. P. Epidemiology of CHD: the Framingham Study. Am. J. Med. 76(2A):4-12, 1984.
13. CHAMBERLAIN, D., and J. HOWARD. Guanethidine and methyldopa: a haemodynamic study.Br. Heart J. 26:528-536, 1964.
14. CHOQUETTE, G., and R. FERGUSON. BPs reduction in "borderline" hypertensives following physical training. Can. Med. Assoc. J. 108:699-703, 1973.
15. CHRISTENSEN, N., and O. BRANDSBORG. The relationship between plasma catecholamine concentration and pulse rate during exercise and standing. Eur. J. Clin. Invest. 3:299-306, 1973.
16. CONONIE, C. C., J. E. GRAVES, M. L. POLLOCK, M. I. PHILLIPS, C. SUMNERS, and J. M. HAGBERG. Effect of exercise training on BP in 70-to-79-yr-old men and women. Med. Sci. Sports Exerc. 23:505-511, 1991.
17. ELLESTAD, M. D. Stress Testing. Principals, and Practice. Philadelphia: F. A. Davis, 1986, pp. 367-380.
18. FAGARD, R., A. AMERY, T. REYBROUCK. et al. Effects of angiotensin antagonism on hemodynamics, renin, and catecholamines during exercise. J. Appl. Physiol. 43:440-444, 1977.
19. FAGARD, R., P. LIJNEN, and A. AMERY. Hemodynamic response to captopril at rest and during exercise in hypertensive patients. Am. J. Cardiol. 49:1569-1571, 1982.
20. FAGENBERG, B., O. V. ANDERSSON, B. ISAKSSON, and P. BJORNTROP. BP control during weight reduction in obese hypertensive men: separate effects of sodium and energy restriction. Br. Med. J. 288:11-14, 1984.
21. FALKNER, B., D. T. LOWENTHAL, and G. ONESTI. Response to centrally acting antihypertensive agents in adolescent hypertension. In: Hypertension in the Young and Old, G. Onesti and K. E. Kim (Eds.). New York: Grund and Stratton, 1981, pp. 203-209.
22. FALKNER, B., D. T. LOWENTHAL, and M. B. AFFRIME. Pharmacodynamic effectiveness of metoprolol in adolescent hypertension of varying etiology. Clin. Pharmacol. Ther. 29:243-244, 1981.
23. FALKNER, B., D. T. LOWENTHAL, and M. B. AFFRIME. The pharmacodynamic effectiveness of metoprolol in adolescent hypertension. J. Pediatr. Pharmacol. 2:49-55, 1982.
24. FALKNER, B., G. ONESTI, D. T. LOWENTHAL, and M. B. AFFRIME. Effectiveness of centrally acting drugs and diuretics in adolescent hypertension. Clin. Pharmacol. Ther. 32:577-583, 1982.
25. FALKNER, B., G. ONESTI, M. B. AFFRIME, and D. T. LOWENTHAL. Effects of clonidine and hydrochlorothiazide on the cardiovascular response to mental stress in adolescent hypertension. Clin. Sci. 63:455S-458S, 1982.
26. FELSON, D. T., and Y. ZHANG. Weight loss reduces the risk for symptomatic knee osteoarthritis in women: The Framingham Study. Ann. Intern. Med. 116:535-539, 1992.
27. GATES, G. A., J. SAEGERT, N. WILSON, L. JOHNSON, A. SHEPHERD, and E. M. HEARNE III. Effect of beta blockage on singing performance. Ann. Otol. Rhinol. Laryngol. 94:570-574, 1985.
28. GERSTENBLITH, G., J. FREDERICKSON, F. C. P. YIN, et al. Echocardiographic assessment of a normal aging population. Circulation 56:273-278, 1977.
29. GIBBONS, D. O., and M. PHILLIPS. The effect of acebutolol on tachycardia and performance during competition rifle shooting. Br. J. Clin. Pharmacol. 3:516-517, 1976.
30. GINKS, W., and D. REDWOOD. Haemodynamic effects of hydralazine at rest and during exercise in patients with chronic heart failure. Br. Heart J. 44:259-264, 1980.
31. GOLDBERG, A. P. Aerobic and resistance exercise modify risk factors for CHD. Med. Sci. Sports Exerc. 21:669-674, 1989.
32. GORDON, N., P. KRUGER, J. VAN RENSBURG, A. VAN DER LINDE, A. KIELBLOCK, and J. CILLIERS. Effect of β-adrenoceptor blockade on thermoregulation during prolonged exercise. J. Appl. Physiol. 58:899-906, 1985.
33. 1 selective adrenoceptor blockage on physiological response to exercise. Br. Heart J. 54:96-99, 1985.
34. GREENDALE, G., E. BARRETT-CONNOR, S. INGLES, and R. HAILE. Late physical and functional effects of osteoporotic fractures in women: the Rancho Bernardo Study. J. Am. Geriatr. Soc. 43: 955-961, 1995.
35. HAGAN, R. D., S. J. UPTON, L. WONG, and J. WHITTAN. The effects of aerobic conditioning and/or calorie restriction in overweight men and women. Med. Sci. Sport. Exerc. 18:87-94, 1986.
36. HAGBERG, J. M. Exercise, fitness, and hypertension. In: Exercise, Fitness, and Health, C. Bouchard, R. J. Shephard, T. Stephens, J. R. Sutton, and B. D. McPherson (Eds.). Champaign, IL: Human Kinetics Press, 1988, pp. 455-466.
37. HAGBERG, J. M., A. A. EHASANI, D. GOLDRING, A. HERNANDEZ, D. R. SINACORE, and J. O. HOLLOSZY. Effect of weight training on BP and hemodynamic in hypertensive adolescents. J. Pediatr. 104:147-151, 1984.
38. HAGBERG, J. M., D. GOLDRING, A. A. EHSANI, et al. Effect of exercise training on the BP and hemodynamic features of hypertensive adolescents. Am. J. Cardiol. 52:763-768, 1983.
39. HAGBERG, J. M., J. GRAVES, M. LIMACHER, et al. Cardiovascular responses of 70-79 y ear old men and women to exercise training. J. Appl. Physiol. 66:2589-2594, 1989.
40. HAGBERG, J. M., S. J. MONTAIN, W. H. MARTIN, and A. A. EHSANI. Effect of exercise training on 60-69 year old persons with essential hypertension. Am. J. Cardiol. 64:348-353, 1989.
41. HAKKI, H., T. W. HARE, A. S. ISKANDRIAN, D. T. LOWENTHAL, and B. L. SEGAL. Prediction of maximal HRs in men and women. Cardiol. Rev. Rep. 4:997-999, 1983.
42. HAKKI, H., B. M. MUNLEY, S. HADJIMIL TIADES, M. D. MEISSMER, and A. S. ISKANDRIAN. Determinance of abnormal BP response to exercise in coronary artery disease. Am. J. Cardiol. 57:71-75, 1986.
43. 1-receptor blocking agent metoprolol. II. Effect of submaximal work and insulin-induced hypoglycemia on plasma catecholamines and renin activity, BP, and pulse rate. Eur. J. Clin. Pharmacol. 11:247-254, 1977.
44. HARE, T. W., D. T. LOWENTHAL, H. HAKKI, and M. J. GOODWIN. Demonstration of training effect in elderly patients with coronary artery disease receiving beta adrenergic blocking drugs. Ann. Sports Med. 2:36-40, 1984.
45. HARE, T. W., D. T. LOWENTHAL, H. HAKKI, and M. J. GOODWIN. Training effect in elderly patients with coronary artery disease on beta adrenergic blocking drugs. Ann. Sports Med. 2:36-40, 1984.
46. HARRIS, K. A., and R. G. HOLLY. Physiological responses to circuit weight training in borderline hypertensive subjects. Med. Sci. Sports Exerc. 19:246-252, 1987. Am. Geriatr. Soc. 19: 1006-1012, 1971.
47. HARRIS, K. A., and R. G. HOLLY. Physiological responses to circuit weight training in borderline hypertensive subjects. Med. Sci. Sports Exerc. 19:246-252, 1987. Am. Geriatr. Soc. 19: 1006-1012, 1971.
48. HARTZELL, A., B. FREUND, S. JILKA, et al. The effect of beta-adrenergic blockade on ratings of perceived exertion during submaximal exercise before and following endurance training. J. Cardiopulmon. Rehabil. 6:444-456, 1986.
49. JENNINGS, G. L., G. DEAKIN, E. DEWAR, E. LAUFER, and L. NELSON. Exercise, cardiovascular disease and BP. Clin. Exp. Hypertens. 11:1035-1052, 1989.
50. KAPLAN, N. M. The deadly quarter: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Int. Med. 149:1514-1520, 1989.
51. KAPLAN, N. M. Estrogen replacement therapy: effect on BP and other cardiovascular risk factors. J. Reprod. Med. 39(Suppl.): 802-808, 1985.
52. KATZ, M., and D. T. LOWENTHAL. Influences of age and exercise on glucose metabolism. South. Med. J. 87(5):S70-S73, 1994.
53. KELEMEN, M. H. Resistance training safety and assessment guideline for cardiac and coronary prone patients. Med. Sci. Sports Exerc. 21:675-677, 1989.
54. KIVELOFF, B., and O. HUBER. Brief maximal isometric exercise in hypertension. J. Am. Geriatr. Soc. 19:1006-1012, 1971.
55. KNOCHEL, J. P. Neuromuscular manifestations of electrolyte disorders. Am. J. Med. 72:521-535, 1982.
56. KNOCHEL, J. P., and E. N. SCHLEIN. On the mechanism of rhabdomyolysis in potassium depletion. J. Clin. Invest. 51:1750-1758, 1972.
57. KOKKINOS, P. F., P. NARAYAN, J. A. COLLERAN, et al. Effects of regular exercise on BP and left ventricular hypertrophy in African-American men with severe hypertension. N. Engl. J. Med. 333:1462-1467, 1995.
58. KROTKIEWSKI, M., K. MANDROUKAS, L. SJOSTROM, L. SULLIVAN, H. WETTERQVIST, and P. BJORNTROP. Effects of long-term physical training on body fat, metabolism, and BP in obesity. Metabolism 28:650-658, 1979.
59. LANG, R., U. ELKAYAM, L. YELLEN, et al. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure: the Losartan Pilot Exerc. Study Investigators. J. Am. Coll. Cardiol. 30:982-991, 1997.
60. LEITCH, A., J. HOPKIN, D. ELLIS, D. CLARKSON, S. MERCHANT, and G. MCHARDY. Failure of propranolol and metoprolol to alter ventilatory responses to carbon dioxide and exercise. Br. J. Clin. Pharmacol. 9:493-498, 1980.
61. LIE, H., R. MUNDAL, and J. ERIKSSEN. Coronary risk factors in incidence of coronary death in relation to physical fitness: 7-year follow-up study of middle-aged and elderly men. Eur. Heart J. 6:147-157, 1985.
62. LIJNEN, P., A. AMERY, R. FAGARD, T. REYBROUCK, E. MOERMAN, and A. DE SCHAEPDRYVER. The effect of beta-adrenoceptor blockade on renin, angiotensin, aldosterone and catecholamines at rest and during exercise. Br. J. Clin. Pharmacol. 7:175-181, 1979.
63. LIMACHER, M. C. Aging and cardiac function: influence of exercise. South. Med. J. 87(5):S13-S16, 1994.
64. LIND, T., E. C. CAMERON, W. M. HUNTER, et al. Prospective controlled trial of six forms of hormone replacement therapy given to postmenopausal women. Br. J. Obstet. Gynaecol. 86(Suppl. 3):1-29, 1979.
65. LINDSAY, R., and B. S. HERRINGTON. Estrogens and osteoporosis. Semin. Reprod. Endocrinol. 1:55-61, 1983.
66. LOWENTHAL, D. T., and M. L. POLLOCK. Cardiac response to exercise in health and disease. In: Seminars in Respiratory Medicine, N. K. Wenger and B. Make (Eds.). New York: Brian C. Division Stratton, 1993, pp. 91-105.
67. LOWENTHAL, D. T., D. DICKERMAN, S. D. SARIS, B. FALKNER, and T. W. HARE. The effect of pharmacologic interaction on central and peripheral alpha-receptors and pressor response to static exercise. Ann. Sports Med. 1:100-104, 1983.
68. LOWENTHAL, D. T., M. B. AFFRIME, B. FALKNER, S. D. SARIS, H. HAKKI, and L. S. ROSENTHAL. Potassium disposition and neuroendocrine effects of propranolol, methyldopa and clonidine during dynamic exercise. Clin. Exp. Hypertens. 4:1895-1911, 1982.
69. LOWENTHAL, D. T., M. AFFRIME, L. ROSENTHAL, J. BORRUSO, and B. FALKNER. Dynamic and biochemical responses to single and multiple dose clonidine during dynamic physical activity. Clin. Pharmacol. Ther. 32:18-24, 1982.
70. LOWENTHAL, D. T., S. SARIS, J. PACKER, A. HARATZ, and K. C. CONRY. The mechanisms of action and the clinical pharmacology of beta adrenergic blocking drugs. Am. J. Med. 77(Suppl. 4A): 119-127, 1984.
71. LUND-JOHANSEN, P. Hemodynamic changes in long-term alpha methyldopa therapy of essential hypertension. Acta Med. Scand. 192:221-226, 1972.
72. LUND-JOHANSEN, P. Hemodynamic changes in long-term diuretic therapy of essential hypertension. A comparative study of chlorthalidone, polythiazide and hydrochlorothiazide. Acta Med. Scand. 1987:509-518, 1970.
73. LUND-JOHANSEN, P. Hemodynamic changes at rest and during exercise in long-term clonidine therapy of essential hypertension. Acta Med. Scand. 195:111-117, 1974.
74. LUND-JOHANSEN, P. Hemodynamic in the hypertension. Acta Med. Scand. 181:1-10, 1967.
75. LUNDBORG, P., H. ASTROM, C. BENGTSSON, et al. Effect of beta-adrenoreceptor blockade on exercise performance and metabolism. Clin. Sci. 61:299-305, 1981.
76. LUOTOLA, H. BP and hemodynamics in postmenopausal women during estradiol-17β substitution. Ann. Clin. Res. 15(Suppl. 38): 1-121, 1983.
77. MACDOUGALL, J. D., D. TUXEN, D. G. SALE, J. R. MOROZ, and J. R. SUTTON. Arterial BP response to heavy resistance exercise. J. Appl. Physiol. 58:785-790, 1985.
78. MACMAHON, S. W., G. J. MACDONALD, L. BERNSTEIN, G. ANDREWS, and R. B. BLACKET. Comparison of weight reduction with metoprolol in treatment of hypertension in young overweight patients. Lancet 1:1233-1236, 1978.
79. MASHCHAK, C. A., and R. A. LOBO. Estrogen replacement therapy and hypertension. J. Reprod. Med. 30(Suppl. 10):805-810, 1985.
80. MENHEM, P., M. BRAMNERT, U. L. HULTHEN, and B. HOKFELT. The effect of captopril on catecholamines, renin activity, angiotensin II and aldosterone in plasma during physical exercise in hypertensive patients. Eur. J. Clin. Invest. 11:389-395, 1981.
81. MONTOYE, H. J., H. L. METZER, and J. B. KELLER. Habitual activity and BP. Med. Sci. Sports 4:175-181, 1972.
82. MOSKOWITZ, R. M., P. A. PICCINI, G. NACARELLI, and R. SELIS. Nifedipine therapy for stable angina pectoris: preliminary results of effects on angina frequency and treadmill exercise response. Am. J. Cardiol. 44:811-816, 1979.
83. MOYER, J. Hydralazine (Apresoline) hydrochloride: pharmacological observations and clinical results in the therapy of hypertension. Arch. Intern. Med. 91:419-439, 1953.
84. NATIONAL RESEARCH COUNCIL. Diet and Health: Implications for Reducing Chronic Disease. Washington, DC: National Academy Press, 1989.
85. NAUGHTON, J. P., and R. HAIDER. Methods of exercise testing. In: Exercise Testing and Exercise Training in CHD, J. P. Naughton, H. K. Hellerstein, and L. C. Mohler (Eds.). New York: Academic Press, pp. 79-91, 1973.
86. NELSON, G., G. DONNELLY, and S. HUNYOR. Haemodynamic effects of sustained treatment with prazosin and metoprolol, alone and in combination, in borderline hypertensive heart failure. J. Cardiovasc. Pharmacol. 4:240-245, 1982.
87. NOTELOVITZ, M. Estrogen replacement therapy: indications, contradictions, and agent selection. Am. J. Obstet. Gynecol. 161: 1832-1841, 1989.
88. NUTRITION LABELING AND EDUCATION ACT OF 1990. Public Law No. 101-535. Code of Federal Regulation Title 21.
89. O'HARE, J., and D. MURNAGHAN. Failure of antihypertensive drugs to control BP rise with isometric exercise in hypertension. Postgrad. Med. J. 57:552-555, 1981.
90. ONESTI, G., A. SCHWARTZ, K. KIM, V. PAZ-MARTINEZ, and C. SWARTZ. Antihypertensive effect of clonidine. Circ. Res. 28(Suppl. 2):53-69, 1971.
91. PAFFENBARGER, R. S., JR., R. T. HYDE, A. L. WING, I. M. LEE, D. L. JUNG, and J. B. KAMPERT. The association of changes in physicalactivity level and other lifestyle characteristics with mortality among men. N. Engl J. Med. 328:538-545, 1993.
92. PAFFENBARGER, R. S., D. L. JUNG, R. W. LEUNG, and R. T. HYDE. Physical activity and hypertension: an epidemiological view. Ann. Med. 23:319-327, 1991.
93. PARAN, E., L. NEUMANN, N. NATALIO, and D. T. LOWENTHAL. Response to mental and physical stress before and during adrenoreceptor blocker and angiotensin-converting enzyme inhibitor treatment in essential hypertension. Am. J. Cardiol 68:1362-1366, 1991.
94. POLLOCK, M., D. LOWENTHAL, C. FOSTER, et al. Acute and chronic responses to exercise in patients treated with beta blockers. J. Cardiopulmon. Rehabil. 11:132-144, 1991.
95. POLLOCK, M., and J. WILMORE. In: Exercise in Health and Disease. Philadelphia: W. B. Saunders, 1990, p. 66.
96. PORT, S., F. R. COBB, R. E. COLEMAN, and R. H. JONES. Effect of age on the response of the left ventricular ejection fraction to exercise. N. Engl. J. Med. 303:1133-1137, 1980.
97. PRATT, C. M., D. E. WELTON, W. G. SQUIRES, T. E. KIRBY, G. H. HARTUNG, and R. R. MILLER. Demonstration of straining effect during chronic beta-adrenergic blockade in patients with coronary artery disease. Circulation 64:1125-1129, 1981.
98. REAVEN G. M., H. LITHELL, and L. LANDSBERG. Hypertension and associated abnormalities - the role of insulin resistance and the sympathoadrenal system. N. Engl. J. Med. 334:374-381, 1996.
99. REIS, S. E., S. T. GLOTH, R. S BLUMENTHAL, et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 89:52-60, 1994.
100. REISEN, E., R. ABEL, M. MODAN, D. S. SILVERBERG, H. E. ELIAHOU, and B. MODAN. Effect of weight loss without salt restriction on the reduction of BP in overweight hypertensive patients. N. Engl. J. Med. 298:1-6, 1978.
101. RIGGS, B. L., L. JOWSEY, P. J. KELLEY, J. D. JONES, and F. T. MAHER. The effect of sex hormones on bone in primary osteoporosis. J. Clin. Invest. 48:1065-1072, 1969.
102. ROMAN, O., A. L. CAMUZZI, E. VILLALON, and C. KLENNER. Physical training program in arterial hypertension: a long-term prospective follow-up. Cardiology 67:230-243, 1981.
103. RONTOYANNIS, P. G. Diet and exercise in the prevention of cardiovascular disease. In: Nutrition and Fitness in Health and Disease, A. P. Simpopoulos (Eds.). Basel: Karger, 1993, pp. 9-22.
104. ROSENTHAL, L., M. AFFRIME, D. LOWENTHAL, B. FALKNER, S. SARIS, and A. B. GOULD. Biochemical and dynamic responses to single and repeated doses of methyldopa and propranolol during dynamic physical activity. Clin. Pharmacol. Ther. 32:701-710, 1982.
105. ROSS, R. K., A. PAGANINI-HILL, T. M. MACK, and B. E. HENDERSON. Estrogen use and cardiovascular disease. In: Menopause: Physiology and Pharmacology, D. R. Mishell (Ed.). Chicago: Year Book Medical Publishers, 1987, pp. 209-223.
106. ROSS, R. K., M. C. PIKE, B. E. HENDERSON, T. M. MACK, and R. A. LOBO. Stroke prevention and estrogen replacement. Lancet 1:505, 1989.
107. SANNERSTEDT, R., E. VARNANSES, and L. WERKO. Hemodynamic effects of methyldopa (Aldomet) at rest and during exercise in patients with arterial hypertension. Acta Med. Scand. 171:75-82, 1962.
108. SEALS, D. R., H. G. SILVERMAN, M. J. REILING, and K. P. DAVY. Effect of regular aerobic exercise on elevated BP in postmenopausal women. Am. J. Cardiol. 80:49-55, 1997.
109. SHEP COOPERATIVE RESEARCH GROUP. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 256:3255-3264, 1991.
110. SHEPS, D. S., J. C. ERNST, F. W. BRIESE, and R. J. MYERBURG. Exercise-induced increase in diastolic pressure: indicator of severe coronary artery disease. Am. J. Cardiol. 43:708-712, 1979.
111. SKLAR, J., D. G. JOHANSTON, P. OVERLIE, et al. The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta adrenergic blocker on the response to dynamic exercise in normal men. Circulation 65:894-899, 1982.
112. SPARLING, P. B., and J. D. CANTWELL. Strength training guidelines for cardiac patients. Physician Sportsmed. 17:191-194, 1989.
113. STAESSEN, J., R. FAGARD, P. LIJNEN, and A. AMERY. Body weight, sodium intake and BP. J. Hypertens. 7(Suppl. 1):S19-S23, 1989.
114. STEIN, D. T., D. T. LOWENTHAL, R. S. PORTER, B. FALKNER, E. L. BRAVO, and T. W. HARE. Effects of nifedipine and verapamil on isometric and dynamic exercise in normal subjects. Am. J. Cardiol. 54:386-389, 1984.
115. STEWART, K. J. Resistance training effects on strength and cardiovascular endurance in cardiac and coronary prone patients. Med. Sci. Sports Exerc. 21:678-682, 1989.
116. STONE, P. H., E. M. ANTMAN, J. E. MULLER, and E. BRAUNWALD. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: hemodynamic effects of clinical applications. Ann. Int. Med. 93:886-904, 1980.
117. SUBRAMANIAN, B., M. J. BOWELS, A. B. DAVIES, and E. B. RAFTERY. Combined therapy with verapamil and propranolol in chronic stable angina. Am. J. Cardiol. 49:125-132, 1982.
118. SUTTON, R. A. L. Clinical aspects of nephrocalcinosis. In: Nephrocalcinosis, Calcium Antagonists and Kidney, K. H. Bichler and W. L. Strohmaier (Eds.). Berlin: Springer-Verlag, 1998, pp. 105-112.
119. TAYLOR, W. C., B. FALKNER, and D. T. LOWENTHAL. Hemodynamic response to isometric exercise in normotensive and hypertensive adolescent females. Ann. Sports Med. 2:26-29, 1984.
120. TERRY, A. H. Obesity and hypertension. JAMA 31:1283-1284, 1923.
121. THE TRIALS OF HYPERTENSION PREVENTION COLLABORATIVE RESEARCH GROUP. The Trials of Hypertension Prevention, Phase II. Arch. Intern. Med. 157:225-229, 1997.
122. TIPTON, C. M. Exercise, training and hypertension. Exerc. Sports Sci. Rev. 12:245-306, 1984.
123. TWENTYMAN, O., A. DISLEY, H. GRIBBIN, K. ALBERTI, and A. TATTERSFIELD. Effect of beta adrenergic blockade on respiratory and metabolic responses to exercise. J. April. Physiol. 51:788-793, 1981.
124. U.S. DEPARTMENT OF AGRICULTURE. USDA's Food Guide Pyramid, Home and Garden Bulletin No. 249. Washington, DC: U.S. Department of Agriculture, 1992.
125. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. Healthy People 2000: National Health Promotion and Disease Prevention Objectives. SHHS Publication No. (PHS)91-50212. Washington, DC: U.S. Government Printing Office, 1991.
126. U. S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. Physical activity and health: a report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion, 1996.
127. VIRTANEN, J., J. JANNE, and M. FRICK. Response of BP and plasma norepinephrine to propranolol, metoprolol and clonidine during isometric and dynamic exercise. Eur. J. Clin. Pharmacol. 21: 275-279, 1982.
128. WEINBERGER, M. H., S. J. COHEN, J. Z. MILLER, F. C. LUFT, C. E. GRIM, and N. S. FINEBERO. Dietary sodium restriction as adjunctive treatment of hypertension. JAMA 259:2561-2565, 1988.
129. WILLETT, W. C. Diet and health: what should we eat? Science 246:532-537, 1994.
130. WILLIAMS, J. K., M. R. ADAMS, and H. S. KLOPFENSTEIN. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81:1680-1687, 1990.
131. WILSON, J., W. UNTERERER, and J. HURSHFELD. Effects of isosorbide dinitrate and hydralazine on regional metabolic responses to arm exercise in patients with heart failure. Am. J. Cardiol. 48: 934-938, 1981.
132. WOOD, P. D., W. L. HASKELL, H. KELIN, S. LEWIS, M. P. STERN, and J. W. FRAQUHAR. The distribution of plasma lipoproteins in middle-aged male runners. Metabolism 25:1249-1257, 1976.
133. WREG, B. G., and D. A. ROUTLEDGE. BP changes: oestrogens in climacteric women. Med. J. Aust. 2:528-531, 1981.
134. WREG, B. G., and D. A. ROUTLEDGE. The effect of type and dose of oestrogen on the BP of postmenopausal women. Maturitas 5:135-142, 1983.
135. WYNDER, E. L., J. H. WEISBURGER, and S. K. NG. Nutrition: the need to define optimal intake as a basis for public policy decisions. Am. J. Public Health 82:346-350, 1992.
136. YAMAUCHI, K., H. FURUI, M. IWASE, S. KAMIHARA, and H. HAYASHI. Effects of enalapril on the cardiovascular response to treadmill exercise in patients with mild to moderate systemic hypertension. Clin. Ther. 11:755-761, 1989.
137. YOUNG, T. K., and D. E. GELSKEY. Is noncentral obesity metabolically benign? Implications for prevention from a population survey. JAMA 274:1939-1941, 1995.